Here are a few products to consider. Topical treatments, like creams, balms, and salves, may have some benefits for arthritis pain. It’s unclear how well the compounds pass through the skin barrier.

More than 40 percent of arthritis sufferers in the U.S. report using ... compound that is similar to commercially available products and to document the mechanisms by which it reduces the effects ...

In a groundbreaking new study, Ozempic was found to be so effective at treating arthritis that people no longer needed ...

Arthritis is a medical condition that affects millions worldwide, characterized by inflammation, pain, and stiffness of the joints, which can impair movement. Frequently, the feet bear the brunt ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Everyday Health shares their favorite organizations for rheumatoid arthritis support and information on how best to manage ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

DelveInsight’s Rheumatoid Arthritis pipeline report depicts a robust space with 95+ active players working to develop 100+ pipeline therapies for Rheumatoid Arthritis treatment.

Novo Nordisk’s drug helped reduce knee pain in osteoarthritis patients with obesity. Meanwhile, the Change Healthcare breach ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

These waits steal lives ("Longer A&E stays see hip patients 'more likely to die'", The Herald, October 9). It is unacceptable that hundreds of thousands of people with arthritis are being left in ...